MedPath

Effectiveness of dry needling compared to placebo needling for easing pain and disability among adults with migraine headache: A Randomized Controlled Trial

Not Applicable
Not yet recruiting
Conditions
Migraine Headache
Registration Number
SLCTR/2024/009
Lead Sponsor
niversity of Peradeniya
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

•Adult patients with migraine headache
* Minimum age 18 and maximum age 50 years
•Diagnosis should be confirmed by a consultant neurologist based on the International Classification
of Headache Disorders (ICHD-3).
•Patients should have at least one active trigger point in their suboccipital and cervical musculature.

Exclusion Criteria

•Patient with a history of neck trauma, cervical radiculopathy
•Patients with previous surgery on the neck or shoulder area
•Patients with abnormal bleeding tendencies, a severely compromised immune system, vascular
disease
•Frail patients,
•Patients with epilepsy
•Patient allergic to metals or latex
•Patients with altered psychological status,
•Patient with prosthetic implants, and implantable electrical devices.
•Patients with a history of physiotherapy intervention in the neck and shoulder region in the previous
six months
•Pregnancy
•Patients with needle phobia
•Patients who are on anticoagulant therapy
•Patients with thrombocytopenia and those with lymphedema in a specific area or limb.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.